Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Catherine Kegakilwe Koofhethile, Ph.D.

Concepts (71)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Proviruses420233131.750 Why?
HIV-18202468501.000 Why?
HIV Infections122024171590.730 Why?
HIV Seropositivity220239550.720 Why?
Viremia220247080.620 Why?
Virus Activation120193190.590 Why?
DNA, Viral2202221950.540 Why?
Viral Load6202433230.530 Why?
Antiretroviral Therapy, Highly Active3202418940.480 Why?
T-Lymphocytes, Cytotoxic2201617650.340 Why?
Histocompatibility Antigens Class I1201613540.340 Why?
CD8-Positive T-Lymphocytes4201645540.310 Why?
Botswana4202410420.280 Why?
CD4-Positive T-Lymphocytes3202343550.250 Why?
Leukocytes, Mononuclear2202318280.250 Why?
Immunodominant Epitopes220152410.230 Why?
HIV-2120231560.210 Why?
Mozambique12022550.210 Why?
Oxazines120243410.200 Why?
Heterocyclic Compounds, 3-Ring120242750.190 Why?
Epitopes, T-Lymphocyte320158250.190 Why?
Pyridones120247880.160 Why?
gag Gene Products, Human Immunodeficiency Virus220152060.140 Why?
HLA-B Antigens220153310.130 Why?
Withholding Treatment120196130.120 Why?
RNA1202327210.110 Why?
Piperazines1202425200.110 Why?
Immune Evasion120143620.090 Why?
Receptors, Antigen, T-Cell2201525360.080 Why?
Virus Replication1201624310.080 Why?
HIV1201415790.070 Why?
HLA Antigens1201013690.060 Why?
Tropism12023430.050 Why?
Humans1220247602610.050 Why?
Epitopes2202325060.050 Why?
Viral Tropism120231020.050 Why?
Epitope Mapping220152970.050 Why?
HIV Integrase Inhibitors120241650.050 Why?
Adolescent22020877470.050 Why?
Adult620242198470.050 Why?
env Gene Products, Human Immunodeficiency Virus120233680.050 Why?
Infant12022360300.040 Why?
Longitudinal Studies12016144820.040 Why?
Infant, Newborn12019261680.040 Why?
Follow-Up Studies12019392540.040 Why?
Treatment Failure1202426460.040 Why?
Time Factors12019401330.040 Why?
HIV Antibodies1202313000.030 Why?
Software1201044200.030 Why?
Antibody Affinity120152450.030 Why?
Anti-HIV Agents2202444920.030 Why?
Antibodies, Neutralizing1202319330.030 Why?
Anti-Retroviral Agents1202317800.030 Why?
DNA, Complementary1201519930.020 Why?
Amino Acid Sequence22015134560.020 Why?
Enzyme-Linked Immunospot Assay120101230.020 Why?
Selection, Genetic120148720.020 Why?
Databases, Protein120103880.020 Why?
Male320243594130.020 Why?
Mutation, Missense1201425630.010 Why?
Sequence Analysis, DNA1201547170.010 Why?
Base Sequence12015124470.010 Why?
Lymphocyte Activation1201454980.010 Why?
Interferon-gamma1201031600.010 Why?
Cohort Studies22014413170.010 Why?
Genotype12014129590.010 Why?
Peptides1201043580.010 Why?
Molecular Sequence Data12010176280.010 Why?
Cell Line12010156260.010 Why?
Middle Aged220242201750.010 Why?
Female320243910110.010 Why?
Koofhethile's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.